Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11510977 Nucleic acid vaccines for coronavirus

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 29, 2022

Patent Application Number

17589703

Date Filed

January 31, 2022

Patent Citations

US Patent 10494636 Polynucleotides encoding α-galactosidase A for the treatment of Fabry disease

US Patent 10406112 Polynucleotides encoding methylmalonyl-CoA mutase

US Patent 10881730 Immunomodulatory therapeutic MRNA compositions encoding activating oncogene mutation peptides

US Patent 10106490 Lipids and lipid nanoparticle formulations for delivery of nucleic acids

US Patent 10285950 Combinations of mRNAs encoding immune modulating polypeptides and uses thereof

Patent Citations Received

US Patent 11878055 Coronavirus vaccine

0

Patent Primary Examiner

Provided herein are therapeutic nucleic acid molecules for managing, preventing and/or treating infectious diseases caused by coronavirus. Also provided herein are therapeutic compositions, including vaccines and lipid nanoparticles, comprising the therapeutic nucleic acids and related therapeutic methods and uses.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11510977 Nucleic acid vaccines for coronavirus

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool